Stock SRTS SENSUS HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.41 USD +2.40% Intraday chart for Sensus Healthcare, Inc. +3.65% +44.49%
Feb. 08 Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Feb. 08 Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
GL
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
AQ
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
GL
Sensus Healthcare to Participate in the 36th Annual Roth Conference
GL
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
GL
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
AQ
Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M
MT
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
GL
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
AQ
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
GL
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
AQ
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
GL
Sensus Healthcare Announces Directors Changes
CI
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
GL
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
AQ
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
GL
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SRTS Stock
  4. News Sensus Healthcare, Inc.